INMB

INMB

USD

INmune Bio Inc. Common stock

$7.860+0.090 (1.158%)

السعر في الوقت الحقيقي

Healthcare
التكنولوجيا الحيوية
الولايات المتحدة

مخطط الأسعار

المقاييس الرئيسية

مقاييس السوق
أساسيات الشركة
إحصاءات التداول

مقاييس السوق

الافتتاح

$7.770

الأعلى

$7.960

الأدنى

$7.755

الحجم

0.02M

أساسيات الشركة

القيمة السوقية

185.7M

الصناعة

التكنولوجيا الحيوية

البلد

United States

إحصاءات التداول

متوسط الحجم

0.32M

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $4.32الحالي $7.860الأعلى $12.72

تقرير تحليل الذكاء الاصطناعي

آخر تحديث: ١٥ أبريل ٢٠٢٥
تم إنشاؤه بواسطة الذكاء الاصطناعيمصدر البيانات: Yahoo Finance, Bloomberg, SEC

[INMB: INmune Bio Inc. Common stock]: Positive News & Price Dip - Opportunity Brewing?

Stock Symbol: INMB Generate Date: 2025-04-15 00:43:25

Alright, let's take a look at INmune Bio (INMB). This is a biotech company, and those can be a bit of a rollercoaster, so let's break down what's happening.

Recent News Buzz: Good Vibes?

The latest news seems pretty upbeat. They just announced a partnership to ramp up manufacturing for one of their treatments, CORDStrom™. Think of it like a company getting ready to sell more of their product – it's a sign they're moving towards actually making money from their research, which is always a good thing for a biotech firm. Before that, they dropped their year-end results and a business update. While year-end reports can be a mixed bag, the fact they're actively giving updates suggests they're trying to keep investors in the loop, which is generally seen as positive. So, news-wise, things are looking reasonably bright for INMB right now.

Price Check: A Bit of a Dip Lately

Now, let's peek at the stock price. Over the last month or so, it's been a bit of a downward slide. We saw it hanging around the $9-$10 range in early February, but it's drifted down to the $7 range more recently. It hasn't been a straight drop – more like a gradual slide with some ups and downs along the way. Looking at today, April 14th, it closed around $7.45.

Interestingly, AI price predictions are hinting at a potential turnaround. They're forecasting small bumps today and tomorrow, and then a more noticeable jump the day after. It's just AI, so grain of salt needed, but it's something to note.

Outlook & Strategy Ideas: Watch Closely, Potential Opportunity?

So, what does this all mean? We've got positive news – they're scaling up production, which is a big step for a biotech. But the stock price has been trending down. This could be a case where the market hasn't fully reacted to the good news yet, or maybe broader market jitters are dragging it down.

Here's a possible angle: This dip might be creating an interesting entry point for those who are optimistic about INMB's future. If you were thinking about getting in, the current price range around $7.40-$7.50 could be worth watching. It's near a potential support level around $7.24 according to some analysis, which could act as a floor.

Thinking about exits and risk: If the stock does bounce back, a potential profit target could be around $8.20 or so – there might be some resistance around that level. On the flip side, to manage risk, a stop-loss somewhere below recent lows, maybe around $6.60, could be a smart move. This is just about protecting yourself if things don't go as hoped.

Important to remember: INMB is a smaller biotech company. They're in the high-risk, high-reward game. News about drug trials and regulatory approvals will likely swing this stock around a lot. Their focus is on immunology and inflammation treatments – areas with big potential, but also lots of competition and hurdles.

In short: The recent news is encouraging, and the price dip combined with AI predictions of a rise suggests a potential buying opportunity if you believe in their long-term prospects. However, biotech is inherently risky. Do your own digging, and don't bet the farm.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. The stock market is inherently risky, and prices can go down as well as up. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

أخبار ذات صلة

GlobeNewswire

INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology

Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announced

عرض المزيد
INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology
GlobeNewswire

INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness

Stevenage, UK, and Boca Raton, Florida, US, April 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune

عرض المزيد
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness
GlobeNewswire

INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update

BOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's

عرض المزيد
INmune Bio Inc.  Announces Year End 2024 Results and Provides a Business Update

تنبؤ الذكاء الاصطناعيBeta

توصية الذكاء الاصطناعي

صعودي

تم التحديث في: ٢٨ أبريل ٢٠٢٥، ٠٢:٢٩ م

هبوطيمحايدصعودي

60.9% الثقة

المخاطر والتداول

مستوى المخاطرة4/5
مخاطرة عالية
مناسب لـ
قيمةعدواني
دليل التداول

نقطة الدخول

$7.77

جني الأرباح

$7.97

وقف الخسارة

$7.03

العوامل الرئيسية

يظهر مؤشر DMI اتجاهًا هبوطيًا (ADX:6.2، +DI:17.3، -DI:18.5)، مما يشير إلى الحذر
السعر الحالي قريب جدًا من مستوى الدعم (7.78 دولار)، مما يشير إلى فرصة شراء قوية
حجم التداول 2.2 ضعف المتوسط (3,584)، مما يدل على اهتمام كبير بالشراء
مؤشر MACD 0.0027 تحت خط الإشارة 0.0036، مما يشير إلى تقاطع هبوطي

ابق على اطلاع

تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.